series-b
Stage
2018
Founded
1
Investors
About
Mirvie is developing a blood test to predict pregnancy complications like preeclampsia, preterm birth, and gestational diabetes by analyzing RNA from the mother, baby, and placenta.
Explore Mirvie's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.